Literature DB >> 23334329

Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.

S M Kumar1, J Dai2, S Li3, R Yang1, H Yu1, K L Nathanson4, S Liu1, H Zhou5, J Guo3, X Xu1.   

Abstract

Adult stem cells are multipotent and persist in small numbers in adult tissues throughout the lifespan of an organism. Unlike differentiated cells, adult stem cells are intrinsically resistant to senescence. It is unclear how adult stem cells in solid organs respond to oncogenic stimulation and whether these cells have a role in tumor initiation. We report here that expression of BRAF(V600E) in human neural crest progenitor cells (hNCPCs) did not induce growth arrest as seen in human melanocytes, but instead, increased their cell proliferation capacity. These cells (hNCPCs(V600E)) acquired anchorage-independent growth ability and were weakly tumorigenic in vivo. Unlike in human melanocytes, BRAF(V600E) expression in hNCPCs did not induce p16(INK4a) expression. BRAF(V600E) induced elevated expression of CDK2, CDK4, MITF and EST1/2 protein in hNCPCs, and also induced melanocytic differentiation of these cells. Furthermore, overexpression of MITF in hNCPCs(V600E) dramatically increased their tumorigenicity and resulted in fully transformed tumor cells. These findings indicate that hNCPCs are susceptible to BRAF(V600E)-induced transformation, and MITF potentiates the oncogenic effect of BRAF(V600E) in these progenitor cells. These results suggest that the hNCPCs are potential targets for BRAF(V600E)-induced melanocytic tumor formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334329      PMCID: PMC3695032          DOI: 10.1038/onc.2012.642

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation.

Authors:  Matthew J Hilton; Xiaolin Tu; Ximei Wu; Shuting Bai; Haibo Zhao; Tatsuya Kobayashi; Henry M Kronenberg; Steven L Teitelbaum; F Patrick Ross; Raphael Kopan; Fanxin Long
Journal:  Nat Med       Date:  2008-02-24       Impact factor: 53.440

Review 2.  Stems cells and the pathways to aging and cancer.

Authors:  Derrick J Rossi; Catriona H M Jamieson; Irving L Weissman
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

3.  Differential gene expression in melanocytic nevi with the V600E BRAF mutation.

Authors:  Sandra Bloethner; Erna Snellman; Justo Lorenzo Bermejo; Eva Hiripi; Andreas Gast; Ranjit K Thirumaran; Ruth Wellenreuther; Kari Hemminki; Rajiv Kumar
Journal:  Genes Chromosomes Cancer       Date:  2007-11       Impact factor: 5.006

4.  Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

Authors:  Sahoko Matsuoka; Yuichi Oike; Ichiro Onoyama; Atsushi Iwama; Fumio Arai; Keiyo Takubo; Yoichi Mashimo; Hideyuki Oguro; Eriko Nitta; Keisuke Ito; Kana Miyamoto; Hiroki Yoshiwara; Kentaro Hosokawa; Yuka Nakamura; Yumiko Gomei; Hiroko Iwasaki; Yasuhide Hayashi; Yumi Matsuzaki; Keiko Nakayama; Yasuo Ikeda; Akira Hata; Shigeru Chiba; Keiichi I Nakayama; Toshio Suda
Journal:  Genes Dev       Date:  2008-03-26       Impact factor: 11.361

5.  Feeder-free growth of undifferentiated human embryonic stem cells.

Authors:  C Xu; M S Inokuma; J Denham; K Golds; P Kundu; J D Gold; M K Carpenter
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

6.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

Review 7.  Telomere dynamics in human cells.

Authors:  Duncan M Baird
Journal:  Biochimie       Date:  2007-08-11       Impact factor: 4.079

8.  Stem cells with neural crest characteristics derived from the bulge region of cultured human hair follicles.

Authors:  Hong Yu; Suresh M Kumar; Andrew V Kossenkov; Louise Showe; Xiaowei Xu
Journal:  J Invest Dermatol       Date:  2009-10-15       Impact factor: 8.551

Review 9.  Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.

Authors:  Sean J Morrison; Allan C Spradling
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

10.  Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.

Authors:  Claudia Wellbrock; Sareena Rana; Hugh Paterson; Helen Pickersgill; Thijn Brummelkamp; Richard Marais
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  9 in total

1.  Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.

Authors:  Ying Ding; Cong Wang; Xuejie Li; Yangyang Jiang; Ping Mei; Wenbin Huang; Guoxin Song; Jinsong Wang; Guoqiang Ping; Ran Hu; Chen Miao; Xiao He; Gang Chen; Hai Li; Yan Zhu; Zhihong Zhang
Journal:  Diagn Pathol       Date:  2018-08-16       Impact factor: 2.644

2.  Ezh2Y641F mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma.

Authors:  Sarah M Zimmerman; Samantha J Nixon; Pei Yu Chen; Leela Raj; Sofia R Smith; Rachel L Paolini; Phyo Nay Lin; George P Souroullas
Journal:  Oncogene       Date:  2022-10-11       Impact factor: 8.756

3.  Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.

Authors:  Wenji Li; Doug Pung; Zheng-Yuan Su; Yue Guo; Chengyue Zhang; Anne Yuqing Yang; Xi Zheng; Zhi-Yun Du; Kun Zhang; Ah-Ng Kong
Journal:  Chem Res Toxicol       Date:  2016-03-29       Impact factor: 3.739

4.  Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.

Authors:  Hanlin Zeng; Aparna Jorapur; A Hunter Shain; Ursula E Lang; Rodrigo Torres; Yuntian Zhang; Andrew S McNeal; Thomas Botton; Jue Lin; Matthew Donne; Ingmar N Bastian; Richard Yu; Jeffrey P North; Laura Pincus; Beth S Ruben; Nancy M Joseph; Iwei Yeh; Boris C Bastian; Robert L Judson
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

5.  Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.

Authors:  Andrea Luchetti; Diana Walsh; Fay Rodger; Graeme Clark; Tom Martin; Richard Irving; Mario Sanna; Masahiro Yao; Mercedes Robledo; Hartmut P H Neumann; Emma R Woodward; Farida Latif; Stephen Abbs; Howard Martin; Eamonn R Maher
Journal:  Int J Endocrinol       Date:  2015-03-25       Impact factor: 3.257

6.  A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.

Authors:  James A Lister; Amy Capper; Zhiqiang Zeng; Marie E Mathers; Jennifer Richardson; Karthika Paranthaman; Ian J Jackson; E Elizabeth Patton
Journal:  J Invest Dermatol       Date:  2013-07-05       Impact factor: 8.551

Review 7.  MITF in melanoma: mechanisms behind its expression and activity.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  Cell Mol Life Sci       Date:  2014-11-30       Impact factor: 9.261

Review 8.  Molecular markers of paragangliomas/pheochromocytomas.

Authors:  Svetlana O Zhikrivetskaya; Anastasiya V Snezhkina; Andrew R Zaretsky; Boris Y Alekseev; Anatoly V Pokrovsky; Alexander L Golovyuk; Nataliya V Melnikova; Oleg A Stepanov; Dmitry V Kalinin; Alexey A Moskalev; George S Krasnov; Alexey A Dmitriev; Anna V Kudryavtseva
Journal:  Oncotarget       Date:  2017-04-11

Review 9.  Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.

Authors:  Farzana Ahmed; Nikolas K Haass
Journal:  Front Oncol       Date:  2018-05-24       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.